Decoy Therapeutics annual operating margin
2016
2017
2018
2019
2020
2021
Decoy Therapeutics Operating Margin Growth & History (DCOY)
Decoy Therapeutics's operating margin was −696.27% for fiscal 2021.
View full Decoy Therapeutics company overviewDecoy Therapeutics annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2021 | 2021-12-31 | −696.27% | −547.49 pp |
| 2020 | 2020-12-31 | −148.78% | +89.74 pp |
| 2019 | 2019-12-31 | −238.53% | −152.20 pp |
| 2018 | 2018-12-31 | −86.33% | +2638.32 pp |
| 2017 | 2017-12-31 | −2,724.65% | +1221.89 pp |
| 2016 | 2016-12-31 | −3,946.54% | — |
Decoy Therapeutics quarterly operating margin
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q2.26
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −1,155.84% | −1028.25 pp |
| Q2 2021 | 2021-06-30 | −545.48% | −392.59 pp |
| Q1 2021 | 2021-03-31 | −142.23% | +66.95 pp |
| Q4 2020 | 2020-12-31 | −118.82% | +79.50 pp |
| Q3 2020 | 2020-09-30 | −127.59% | +302.17 pp |
| Q2 2020 | 2020-06-30 | −152.89% | −51.07 pp |
| Q1 2020 | 2020-03-31 | −209.17% | +24.61 pp |
| Q4 2019 | 2019-12-31 | −198.33% | −1711.76 pp |
| Q3 2019 | 2019-09-30 | −429.76% | −362.92 pp |
| Q2 2019 | 2019-06-30 | −101.82% | +3606.37 pp |
| Q1 2019 | 2019-03-31 | −233.79% | +4404.32 pp |
| Q4 2018 | 2018-12-31 | 1,513.43% | +4374.87 pp |
| Q3 2018 | 2018-09-30 | −66.84% | +2208.17 pp |
| Q2 2018 | 2018-06-30 | −3,708.19% | −1062.48 pp |
| Q1 2018 | 2018-03-31 | −4,638.10% | −1197.02 pp |
| Q4 2017 | 2017-12-31 | −2,861.44% | −190.26 pp |
| Q3 2017 | 2017-09-30 | −2,275.01% | −483.04 pp |
| Q2 2017 | 2017-06-30 | −2,645.71% | +7533.95 pp |
| Q1 2017 | 2017-03-31 | −3,441.09% | — |
| Q4 2016 | 2016-12-31 | −2,671.18% | — |
| Q3 2016 | 2016-09-30 | −1,791.97% | — |
| Q2 2016 | 2016-06-30 | −10,179.66% | — |
Decoy Therapeutics operating margin trends
Over the last five reported fiscal years, Decoy Therapeutics's operating margin increased from −3,946.54% to −696.27%, a change of +3250.27 percentage points. The latest reported quarter, Q2 2026, shows −1,155.84%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Decoy Therapeutics filings at SEC.gov ↗